Emerging CAR T Cell Strategies for the Treatment of AML

SIMPLE SUMMARY: Chimeric antigen receptors (CARs) targeting CD19 have emerged as a new treatment for hematological malignancies. As a “living therapy”, CARs can precisely target and eliminate tumors while proliferating inside the patient’s body. Various preclinical and clinical studies are ongoing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishwasrao, Paresh, Li, Gongbo, Boucher, Justin C., Smith, D. Lynne, Hui, Susanta K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909045/
https://www.ncbi.nlm.nih.gov/pubmed/35267549
http://dx.doi.org/10.3390/cancers14051241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909045/
https://www.ncbi.nlm.nih.gov/pubmed/35267549
http://dx.doi.org/10.3390/cancers14051241

Ejemplares similares